Some researchers have found that the expression of MUS81 is downregulated in human hepatocellular carcinoma, gastric cancer, and colorectal cancer [13–15], and its SNP links to increased risks of breast cancer [16], but its expression was upregulated in ovarian cancer tissues [17–19]. Here, MUS81 is linked to breast carcinoma.